Codivir and Code Pharma were some of the topics discussed in an article on Trade Arabia. Code Pharma Founder and CEO Zyon Ayni quoted: “We are in contact with governments all over the world and expect to get emergency approvals from a substantial number of them by the end of a successful phase II study”.
Ayni added: “We are currently in Dubai and looking for local partners in the UAE and other countries to do local production and distribution”.
TradeArabia also mentioned: “Code Pharma experts currently working on the project include Dr Eynat Finkelshtein and Dr Esmira Naftali and supporting the clinical trials are Dr Yotam Kolben from the Department of Medicine at Hadassah Medical Centre and Prof Shlomo L Maayan, Director Infectious Disease division at the Barzilai Medical Centre in Ashkelon”.
